Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis

References

• Shi J, Knevel R, Suwannalai P, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage [Research Support, Non-U.S. Gov't]. Proc Natl Acad Sci USA. 2011;108:17372–17377.
   PubMed Web of Science ®Google Scholar
• Thiele GM, Duryee MJ, Anderson DR, et al. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol. 2015;67:645–655.
   PubMed Web of Science ®Google Scholar
• Juarez M, Bang H, Hammar F, et al. Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Ann Rheum Dis. 2016;75:1099–1107.
   PubMed Web of Science ®Google Scholar
• Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:331–339.
   PubMed Web of Science ®Google Scholar
• Oimomi M, Ishikawa K, Kawasaki T, et al. Plasma carbamylated protein in renal failure. N Engl J Med. 1983;308:655–656.
   PubMed Web of Science ®Google Scholar
• Butts WC, Kueheman M, Widdowson GM. Automated method for determining serum thiocyanate, to distinguish smokers from nonsmokers. Clin Chem. 1974;20:1344–1348.
   PubMed Web of Science ®Google Scholar
• Felker P, Bunch R, Leung AM. Concentrations of thiocyanate and goitrin in human plasma, their precursor concentrations in brassica vegetables, and associated potential risk for hypothyroidism. Nutr Rev. 2016;74:248–258.
   PubMed Web of Science ®Google Scholar
• Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis [Comparative Study Research Support, N.I.H., Extramural]. Nat Med. 2007;13:1176–1184.
   PubMed Web of Science ®Google Scholar
• Shi J, Willemze A, Janssen GM, et al. Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method. Ann Rheum Dis. 2013;72:148–150.
   PubMed Web of Science ®Google Scholar
• Reed E, Jiang X, Kharlamova N, et al. Antibodies to carbamylated alpha-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies. Arthritis Res Ther. 2016;18:96.
   PubMed Web of Science ®Google Scholar
• Lac P, Racape M, Barra L, et al. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis. J Rheumatol. 2018;45:302–309.
   PubMed Web of Science ®Google Scholar
• Scinocca M, Bell DA, Racape M, et al. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. J Rheumatol. 2014;41:270–279.
   PubMed Web of Science ®Google Scholar
• Martinez G, Gomez JA, Bang H, et al. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients. Rheumatol Int. 2016;36:781–791.
   Web of Science ®Google Scholar
• Yu HC, Lai PH, Lai NS, et al. Increased serum levels of anti-carbamylated 78-kDa glucose-regulated protein antibody in patients with rheumatoid arthritis. Int J Mol Sci. 2016;17. DOI:10.3390/ijms17091510
   Web of Science ®Google Scholar
• Nakabo S, Hashimoto M, Ito S, et al. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. Rheumatology (Oxford). 2017;56:1217–1226.
   PubMed Web of Science ®Google Scholar
• Verheul MK, Yee A, Seaman A, et al. Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis. J Autoimmun. 2017;80:77–84.
   PubMed Web of Science ®Google Scholar
• Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012;7:e35296. doi: 10.1371/journal.pone.0035296.
   PubMed Web of Science ®Google Scholar
• van Delft MAM, Verheul MK, Burgers LE, et al. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. Arthritis Res Ther. 2017;19:190.
   Web of Science ®Google Scholar
• van Delft MAM, Verheul MK, Burgers LE, et al. The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching. Rheumatology (Oxford). 2018;57:1583–1591.
   Web of Science ®Google Scholar
• Suwannalai P, Scherer HU, van der Woude D, et al. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann Rheum Dis. 2011;70:373–379.
   PubMed Web of Science ®Google Scholar
• Jiang X, Trouw LA, van Wesemael TJ, et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis. 2014;73:1761–1768.
   PubMed Web of Science ®Google Scholar
• Li L, Deng C, Chen S, et al. Meta-analysis: diagnostic accuracy of anti-carbamylated protein antibody for rheumatoid arthritis. PLoS One. 2016;11:e0159000.
   PubMedGoogle Scholar
• Shi J, van Steenbergen HW, van Nies JA, et al. The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis. Arthritis Res Ther. 2015;17:339.
   PubMed Web of Science ®Google Scholar
• Ziegelasch M, van Delft MA, Wallin P, et al. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts. Arthritis Res Ther. 2016;18:289.
   PubMed Web of Science ®Google Scholar
• Nakabo S, Yoshifuji H, Hashimoto M, et al. Anti-carbamylated protein antibodies are detectable in various connective tissue diseases. J Rheumatol. 2017;44:1384–1388.
   PubMed Web of Science ®Google Scholar
• Bergum B, Koro C, Delaleu N, et al. Antibodies against carbamylated proteins are present in primary Sjogren's syndrome and are associated with disease severity. Ann Rheum Dis. 2016;75:1494–1500.
   PubMed Web of Science ®Google Scholar
• Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2013;65:911–915.
   PubMed Web of Science ®Google Scholar
• Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis. 2014;73:780–783.
   PubMed Web of Science ®Google Scholar
• Stoop JN, Liu BS, Shi J, et al. Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. PLoS One. 2014;9:e102163.
   Web of Science ®Google Scholar
• Brink M, Verheul MK, Ronnelid J, et al. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis Res Ther. 2015;17:25.
   PubMed Web of Science ®Google Scholar
• Gan RW, Trouw LA, Shi J, et al. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J Rheumatol. 2015;42:572–579.
   Web of Science ®Google Scholar
• Terao C, Ohmura K, Ikari K, et al. Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population. Arthritis Care Res. 2014;66:1818–1827.
   PubMed Web of Science ®Google Scholar
• Ajeganova S, Svensson B, Huizinga TW, et al. Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis. Ann Rheum Dis. 2016;75:e14.
   Web of Science ®Google Scholar
• Akdemir G, Verheul MK, Heimans L, et al. Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study. RMD Open. 2016;2:e000172.
   Web of Science ®Google Scholar
• Humphreys JH, Verheul MK, Barton A, et al. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis. 2016;75:1139–1144.
   PubMed Web of Science ®Google Scholar
• Ajeganova S, van Steenbergen HW, Verheul MK, et al. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ann Rheum Dis. 2017;76:112–118.
   PubMed Web of Science ®Google Scholar
• Truchetet ME, Dublanc S, Barnetche T, et al. Association of the presence of anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort. Arthritis Rheumatol. 2017;69:2292–2302.
   PubMed Web of Science ®Google Scholar
• Spinelli FR, Pecani A, Ciciarello F, et al. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients. BMC Musculoskelet Disord. 2017;18:214.
   PubMed Web of Science ®Google Scholar
• Challener GJ, Jones JD, Pelzek AJ, et al. Anti-carbamylated protein antibody levels correlate with anti-Sa (citrullinated vimentin) antibody levels in rheumatoid arthritis. J Rheumatol. 2016;43:273–281.
   PubMed Web of Science ®Google Scholar
• Koppejan H, Trouw LA, Sokolove J, et al. Role of anti-carbamylated protein antibodies compared to anti-citrullinated protein antibodies in indigenous north americans with rheumatoid arthritis, their first-degree relatives, and healthy controls. arthritis. Rheumatol. 2016;68:2090–2098.
   Web of Science ®Google Scholar
• Turunen S, Huhtakangas J, Nousiainen T, et al. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue. Arthritis Res Ther. 2016;18:239.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–1535.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134–147.
   PubMed Web of Science ®Google Scholar
• Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008;180:1895–1902.
   PubMed Web of Science ®Google Scholar
• Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5:178ra40.
   PubMed Web of Science ®Google Scholar
• Dwivedi N, Neeli I, Schall N, et al. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity. FASEB J. 2014;28:2840–2851.
   PubMed Web of Science ®Google Scholar
• Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity [Review]. Ann Rheum Dis. 2014;73:483–491.
   PubMed Web of Science ®Google Scholar
• Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:593–601.
   PubMed Web of Science ®Google Scholar
• Spengler J, Lugonja B, Ytterberg AJ, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. arthritis. Rheumatol. 2015;67:3135–3145.
   Web of Science ®Google Scholar
• Carmona-Rivera C, Carlucci PM, Moore E, et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci Immunol. 2017;2. doi: 10.1126/sciimmunol.aag3358.
   Web of Science ®Google Scholar
• Nakabo S, Ohmura K, Akizuki S, et al. Protein carbamylation is induced by activated neutrophil: ex vivo analysis [abstract]. Arthritis Rheumatol. 2017;69(Supplement S10):479.
   Google Scholar
• Hill JA, Southwood S, Sette A, et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003;171:538–541.
   PubMed Web of Science ®Google Scholar
• Huizinga TW, Amos CI, van der Helm-van Mil AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005;52:3433–3438.
   PubMed Web of Science ®Google Scholar
• Irigoyen P, Lee AT, Wener MH, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 2005;52:3813–3818.
   PubMed Web of Science ®Google Scholar
• Taneja V, Behrens M, Basal E, et al. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol. 2008;181:2869–2877.
   PubMed Web of Science ®Google Scholar
• Senshu T, Sato T, Inoue T, et al. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem. 1992;203:94–100.
   Web of Science ®Google Scholar
• Nicholas AP, Whitaker JN. Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia. 2002;37:328–336.
   PubMed Web of Science ®Google Scholar
• Turunen S, Koivula M-K, Nicholas AP, et al. Homocitrulline: an analog and confounder related to citrulline. In: Nicholas AP, Bhattacharya SK, editors. Protein Deimination in Human Health and Disease. Springer; 2014. p. 367–376.
   Google Scholar
• Verheul MK, van Veelen PA, van Delft MAM, et al. Pitfalls in the detection of citrullination and carbamylation. Autoimmun Rev. 2018;17:136–141.
   PubMed Web of Science ®Google Scholar
• Slade DJ, Subramanian V, Fuhrmann J, et al. Chemical and biological methods to detect post-translational modifications of arginine. Biopolymers. 2014;101:133–143.
   Web of Science ®Google Scholar
• Turunen S, Koivula MK, Risteli L, et al. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum. 2010;62:3345–3352.
   PubMed Web of Science ®Google Scholar
• Mydel P, Wang Z, Brisslert M, et al. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis [Research Support, Non-U.S. Gov't]. J Immunol. 2010;184:6882–6890.
   PubMed Web of Science ®Google Scholar